Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Concerning Autism Spectrum Claims
Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, alleging the companies hid alleged dangers that the medication posed to pediatric brain development.
The lawsuit follows four weeks after Former President Trump publicized an unsubstantiated connection between using Tylenol - alternatively called acetaminophen - while pregnant and autism spectrum disorder in children.
Paxton is filing suit against the pharmaceutical giant, which previously sold the drug, the sole analgesic approved for women during pregnancy, and Kenvue, which now manufacturers it.
In a statement, he claimed they "misled consumers by gaining financially from suffering and marketing drugs without regard for the risks."
The company asserts there is no credible evidence tying acetaminophen to autism.
"These corporations lied for decades, intentionally threatening numerous people to boost earnings," Paxton, a Republican, declared.
Kenvue commented that it was "seriously troubled by the dissemination of inaccurate information on the reliability of acetaminophen and the likely effects that could have on the health of American women and children."
On its online platform, the company also said it had "consistently assessed the pertinent research and there is lacking reliable evidence that indicates a proven link between consuming paracetamol and autism."
Groups speaking for medical professionals and medical practitioners share this view.
The leading OB-GYN organization has stated paracetamol - the main ingredient in Tylenol - is among limited choices for pregnant women to address discomfort and fever, which can pose significant medical dangers if left untreated.
"In over twenty years of studies on the utilization of paracetamol in pregnancy, not a single reputable study has successfully concluded that the usage of paracetamol in any period of gestation leads to brain development issues in offspring," the association commented.
This legal action references recent announcements from the previous government in arguing the drug is reportedly hazardous.
In recent weeks, the former president caused concern from public health officials when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when ill.
Federal regulators then released a statement that medical professionals should consider limiting the usage of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism in children has not been established.
Health Secretary RFK Jr, who oversees the FDA, had promised in April to conduct "extensive scientific investigation" that would determine the origin of autism in a short period.
But authorities cautioned that discovering a single cause of autism - believed by scientists to be the consequence of a intricate combination of genetic and surrounding conditions - would be difficult.
Autism spectrum disorder is a form of enduring cognitive variation and disability that impacts how people experience and relate to the surroundings, and is diagnosed using medical professional evaluations.
In his court filing, Paxton - aligned with the former president who is running for US Senate - asserts the manufacturer and J&J "deliberately disregarded and attempted to silence the science" around acetaminophen and autism.
The case aims to force the corporations "eliminate any commercial messaging" that asserts Tylenol is secure for pregnant women.
The Texas lawsuit parallels the complaints of a assembly of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of acetaminophen in recently.
Judicial authorities dismissed the lawsuit, stating research from the parents' expert witnesses was inconclusive.